FTC distributes redress
This article was originally published in The Tan Sheet
Executive Summary
More than 5,700 consumers who bought dietary supplements and infrared saunas from Roex Inc. will receive checks averaging $500 from the Federal Trade Commission. The money, totaling $3 million, is redress from Roex for making alleged "bogus claims" that its products treat cancer, AIDs and other diseases, FTC said March 4. Roex, President Rodney Burreson and Mark Alexander, consumer education director, agreed in 2009 to pay the money to resolve false advertising allegations (1"The Tan Sheet" March 9, 2009, In Brief)
You may also be interested in...
Marketers pay $3 million fine
Dietary supplement marketing firm Roex Inc., and its president Rodney Burreson and director of consumer education Mark Alexander will pay $3 million in consumer redress to resolve Federal Trade Commission allegations they falsely advertised their supplements as treatment for cancer, AIDS, diabetes, Alzheimer's disease and other conditions. The settlement announced March 6 bars the marketers from making false claims about any drug, food, supplement or device and from misrepresenting tests and studies while advertising products or services
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.